摘要 |
<p>Compounds of formula (I) in free or salt form, wherein R<sup>1</sup>, R<sup>2</sup> and R<sup>3</sup> have the meanings as indicated in the specification, are useful for treating conditions mediated by activation of the adenosine A<sub>2A</sub> receptor, especially inflammatory or obstructive airways diseases. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.</p> |